We propose that inhibition of NER represents a previously unrecognized feature of the diabetic impairment of HIF-1α that may contribute significantly to genomic instability, enhanced susceptibility to endogenous and exogenous DNA damaging agents, and increased cancer risk. Here, HIF1A is linked to cancer.